From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

被引：4
作者：
Thatcher, Thomas H. [1 ]
Peters-Golden, Marc [2 ]
机构：
[1] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA
[2] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 05期
关键词：
THROMBOXANE A(2); RECEPTOR;
D O I：
10.1164/rccm.202205-0914ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530 / 532
页数：4
相关论文
共 50 条
  • [21] CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling
    Habiel, David M.
    Espindola, Milena S.
    Jones, Isabelle C.
    Coelho, Ana Lucia
    Stripp, Barry
    Hogaboam, Cory M.
    JCI INSIGHT, 2018, 3 (16):
  • [22] Diabetes Mellitus Contributes to Idiopathic Pulmonary Fibrosis: A Review From Clinical Appearance to Possible Pathogenesis
    Wang, Dongguang
    Ma, Yao
    Tong, Xiang
    Zhang, Yonggang
    Fan, Hong
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [23] Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis
    Kida, Taiki
    Ayabe, Shinya
    Omori, Keisuke
    Nakamura, Tatsuro
    Maehara, Toko
    Aritake, Kosuke
    Urade, Yoshihiro
    Murata, Takahisa
    PLoS One, 2016, 11 (12):
  • [24] DROSHA-Dependent miRNA and AIM2 Inflammasome Activation in Idiopathic Pulmonary Fibrosis
    Cho, Soo Jung
    Lee, Mihye
    Stout-Delgado, Heather W.
    Moon, Jong-Seok
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (05)
  • [25] Reduced production of isoprostanes by peri-pancreatic adipose tissue from Zucker fa/fa rats as a new mechanism for β-cell compensation in insulin resistance and obesity
    Laget, Jonas
    Vigor, Claire
    Nouvel, Agathe
    Rocher, Amandine
    Jeanson, Laura
    Reversat, Guillaume
    Oger, Camille
    Galano, Jean-Marie
    Durand, Thierry
    Azay-Milhau, Jacqueline
    Lajoix, Anne-Dominique
    Leroy, Jeremy
    Peraldi-Roux, Sylvie
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 182 : 160 - 170
  • [26] ST2 as a Cardiovascular Risk Biomarker: From the Bench to the Bedside
    Januzzi, James L., Jr.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2013, 6 (04) : 493 - 500
  • [27] IL-33/ST2 pathway in a bleomycin-induced pulmonary fibrosis model
    Xu, Jiao
    Zheng, Jinxu
    Song, Ping
    Zhou, Yanjuan
    Guan, Shuhong
    MOLECULAR MEDICINE REPORTS, 2016, 14 (02) : 1704 - 1708
  • [28] Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis
    Bruce, E.
    Shenoy, V.
    Rathinasabapathy, A.
    Espejo, A.
    Horowitz, A.
    Oswalt, A.
    Francis, J.
    Nair, A.
    Unger, T.
    Raizada, M. K.
    Steckelings, U. M.
    Sumners, C.
    Katovich, M. J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (09) : 2219 - 2231
  • [29] Effects of cannabinoid receptor 2 synthetic agonist, AM1241, on bleomycin induced pulmonary fibrosis
    Parlar, Ali
    Arslan, Seyfullah Oktay
    Yumrutas, Onder
    Elibol, Ebru
    Yalcin, Alper
    Uckardes, Fatih
    Aydin, Hasan
    Dogan, Muhammed Fatih
    Kayhan Kustepe, Elif
    Ozer, Mehmet Kaya
    BIOTECHNIC & HISTOCHEMISTRY, 2021, 96 (01) : 48 - 59
  • [30] Identifying Mechanism of RSV for the Treatment of COVID-19 and Idiopathic Pulmonary Fibrosis via Suppressing Inflammation Response Through IL-17 Signaling Pathway from the Perspectives of in silico Study
    Wang, Jiahao
    Shi, Jiamiao
    Jia, Ning
    Sun, Qinru
    CURRENT MEDICINAL CHEMISTRY, 2024,
12345